MyFinsight
Home
Blog
About
Sale of fixed
maturity securities,...
$34,369K
(-59.95%↓ Y/Y)
Proceeds from issuance of
common stock and espp
$347K
(189.17%↑ Y/Y)
Sale of property and
equipment
$59K
Net cash provided
(used in) by investing...
$17,767K
(-70.62%↓ Y/Y)
Net cash provided by
financing activities
$311K
(159.17%↑ Y/Y)
Canceled cashflow
$16,661K
Canceled cashflow
$36K
Net decrease in
cash, cash...
-$1,756K
(-8.00%↓ Y/Y)
Canceled cashflow
$18,078K
Loss on lease
component termination
-$11,145K
Depreciation
$2,615K
(-59.28%↓ Y/Y)
Stock-based compensation
$1,950K
(-58.05%↓ Y/Y)
Accounts payable
$1,673K
(41925.00%↑ Y/Y)
Accrued expenses and
other liabilities
$1,158K
(119.84%↑ Y/Y)
Non-cash operating lease
expense (benefit)
$406K
(-58.06%↓ Y/Y)
Acquisition of fixed
maturity securities,...
$15,967K
(-34.97%↓ Y/Y)
Acquisition of property and
equipment
$694K
(-12.37%↓ Y/Y)
Proceeds from pipe, net of
issuance costs
-$36K
Net cash used in
operating activities
-$19,834K
(68.12%↑ Y/Y)
Canceled cashflow
$18,947K
Net income (loss)
-$34,550K
(-178.49%↓ Y/Y)
Change in fair value of
contingent liabilities
$1,939K
(1437.24%↑ Y/Y)
Prepaid expenses and
other assets
$1,155K
(364.91%↑ Y/Y)
Operating lease liability
-$989K
(57.86%↑ Y/Y)
Accretion of investments
$148K
(-90.14%↓ Y/Y)
Back
Back
Cash Flow
Century Therapeutics, Inc. (IPSC)
Century Therapeutics, Inc. (IPSC)
source: myfinsight.com